Dissolution Rate Enhancement, Design and Development of Buccal Drug Delivery of Darifenacin Hydroxypropyl β-Cyclodextrin Inclusion Complexes
Figure 7
In vitro release profile of different formulations of HPMC K15 containing Hpβ-CD-darifenacin complex. Pa1–Pa5 formulations of HPMC K15 containaing 1%–5% of the polymer, D-formulation containing pure drug.